GenePOC introduces GenePOC CDiff Test in Canada
Debiopharm Group member GenePOC has secured approval from Health Canada and launched its GenePOC CDiff assay for use…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
25 Oct 18
Debiopharm Group member GenePOC has secured approval from Health Canada and launched its GenePOC CDiff assay for use…
25 Oct 18
TP Therapeutics and Almac Diagnostic Services have signed a collaboration agreement for the development and commercialization of a…
24 Oct 18
Cancer-focused genetic testing services provider NeoGenomics has agreed to acquire clinical oncology laboratory, Genoptix, for $125m in cash.
23 Oct 18
Siemens Healthineers is set to invest RMB3bn ($433m) to construct a new laboratory diagnostics plant in Shanghai, China.
17 Oct 18
Personalized medicine molecular diagnostics firm Myriad Genetics has secured approval from the US Food and Drug Administration (FDA)…
16 Oct 18
Swiss multinational healthcare firm Roche has introduced three new next-generation sequencing (NGS) Avenio tumor tissue analysis kits for…
15 Oct 18
Spain-based healthcare firm Grifols has secured approval from the US Food & Drug Administration (FDA) for its ID…
10 Oct 18
Personalized medicine company Myriad Genetics has signed a commercialization plan with pharmaceutical giant Pfizer.
08 Oct 18
IQVIA and Genomics England have collaborated to develop a platform, which will connect clinical and de-identified genomics data…
08 Oct 18
Diagnostic information services provider Quest Diagnostics has entered into an agreement to divest its medical diagnostics business in…